Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe–statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia

References

• Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. Lancet 2005;366:1267–78
   PubMed Web of Science ®Google Scholar
• Garcia-Calvo M, Lisnock J, Bull HG, et al. The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Proc Natl Acad Sci USA 2005;102: 8132–7
   Google Scholar
• Ballantyne CM, Houri J, Notarbartolo A, et al. Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial. Circulation 2003;107:2409–15
   PubMed Web of Science ®Google Scholar
• Davidson MH, McGarry T, Bettis R, et al. Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia. J Am Coll Cardiol 2002;40:2125–34
   PubMed Web of Science ®Google Scholar
• Pearson TA, Denke MA, McBride PE, et al. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial. Mayo Clin Proc 2005;80:587–95
   PubMed Web of Science ®Google Scholar
• Berge KE, von Bergmann K, Lütjohann D, et al. Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8. J Lipid Res 2002;43: 486–94
   Google Scholar
• Miettinen TA, Tilvis RS, Kesaniemi YA. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 1990;131:20–31
   Google Scholar
• Tilvis RS, Miettinen TA. Serum plant sterols and their relation to cholesterol absorption. Am J Clin Nutr 1986;43:92–7
   PubMed Web of Science ®Google Scholar
• Kempen HJ, Glatz JF, Devers Leuven JA, et al. Serum lathosterol concentration as an indicator of whole-body cholesterol synthesis in humans. J Lipid Res 1988;80:578–81
   Google Scholar
• Pfohl M, Schreiber I, Liebich HM, et al. Upregulation of cholesterol synthesis after acute myocardial infarction: is cholesterol a positive acute phase reactant? Atherosclerosis 1999;142:389–93
   PubMed Web of Science ®Google Scholar
• Miettinen TA, Gylling H, Lindbohm N, et al. Serum noncholesterol sterols during inhibition of cholesterol synthesis by statins. J Lab Clin Med 2003;141:131–7
   PubMed Web of Science ®Google Scholar
• Matthan NR, Giovanni A, Schaefer EJ, et al. Impact of simvastatin, niacin, and/or antioxidants on cholesterol metabolism in CAD patients with low HDL. J Lipid Res 2003;44:800–6
   PubMed Web of Science ®Google Scholar
• Salen G, von Bergmann K, Lütjohann D, et al. Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia. Circulation 2004;109:966–71
   Google Scholar
• Sudhop T, Lütjohann D, Kodal A, et al. Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Circulation 2002;106:1943–8
   PubMed Web of Science ®Google Scholar
• Kannenberg F. Entwicklung eines neuen Verfahrens zur Analyse von Gallensauren mit Hilfe von Gaschromatographie/Massenspektrometrie-Kopplung. Identifizierung und Quantifizierung abnomer Metaboliten in Galle und Serum bei Storungen des Gallensaurenstoffwechsels [dissertation]. 2000
   Google Scholar
• Klansek JJ, Yancey P, St Clair RW, et al. Cholesterol quantitation by GLC: artifactual formation of short-chain steryl esters. J Lipid Res 1995;36:2261–6
   PubMed Web of Science ®Google Scholar
• Schering-Plough Corp (Kenilworth, NJ). Data on file. CSR #P02788 and P02901; 2007
   Google Scholar
• Lamon-Fava S, Diffenderfer MR, Barrett PHR, et al. Effects of different doses of atorvastatin on human apolipoprotein B-100, B-48, and A-I metabolism. J Lipid Res 2007;48: 1746–53
   Google Scholar
• Santosa S, Varady KA, AbuMweis S, et al. Physiological and therapeutic factors affecting cholesterol metabolism: does a reciprocal relationship between cholesterol absorption and synthesis really exist? Life Sci 2007;80:505–14
   PubMed Web of Science ®Google Scholar
• Gylling H, Miettinen TA. Baseline intestinal absorption and synthesis of cholesterol regulate its response to hypolipidaemic treatments in coronary patients. Atherosclerosis 2002;160:477–81
   PubMed Web of Science ®Google Scholar
• Miettinen TA, Gylling H. Synthesis and absorption markers of cholesterol in serum and lipoproteins during a large dose of statin treatment. Eur J Clin Invest 2003;33:976–82
   PubMed Web of Science ®Google Scholar
• Smith JL, Roach PD, Wittenberg LN, et al. Effects of simvastatin on hepatic cholesterol metabolism, bile lithogenicity and bile acid hydrophobicity in patients with gallstones. J Gastroenterol Hepatol 2000;15:871–9
   PubMed Web of Science ®Google Scholar
• Vanhanen HT, Miettinen TA. Cholesterol absorption and synthesis during pravastatin, gemfibrozil and their combination. Atherosclerosis 1995;115:135–46
   PubMed Web of Science ®Google Scholar
• Assmann G, Cullen P, Erbey J, et al. Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case-control analysis of the Prospective Cardiovascular Munster (PROCAM) study. Nutr Metab Cardiovasc Dis 2006;1613–21
   Web of Science ®Google Scholar
• Gylling H, Miettinen TA. Cholesterol absorption and lipoprotein metabolism in type II diabetes mellitus with and without coronary artery disease. Atherosclerosis 1996;126:325–32
   PubMed Web of Science ®Google Scholar
• Miettinen TA, Gylling H, Strandberg T, et al. Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian Simvastatin Survival Study [Finnish 4S Investigators]. Br Med J 1998;316:1127–30
   PubMed Web of Science ®Google Scholar
• Miettinen TA, Gylling H. Ineffective decrease of serum cholesterol by simvastatin in a subgroup of hypercholesterolemic coronary patients. Atherosclerosis 2002;164:147–52
   PubMed Web of Science ®Google Scholar
• Miettinen TA, Strandberg TE, Gylling H. Noncholesterol sterols and cholesterol lowering by long-term simvastatin treatment in coronary patients: relation to basal serum cholestanol. Arterioscler Thromb Vasc Biol 2000;20:1340–6
   Google Scholar
• Wilund KR, Yu L, Xu F, et al. No association between plasma levels of plant sterols and atherosclerosis in mice and men. Arterioscler Thromb Vasc Biol 2004;24:2326–32
   PubMed Web of Science ®Google Scholar
• Fassbender K, Lütjohann D, Dik MG, et al. Moderately elevated plant sterol levels are associated with reduced cardiovascular risk: the LASA study. Atherosclerosis 2006;28 [epub ahead of print]
   Google Scholar
• Pinedo S, Vissers MN, von Bergmann K, et al. Plasma levels of plant sterols and the risk of coronary artery disease: the prospective EPIC-Norfolk Population Study. J Lipid Res 2007;48:139–44
   PubMed Web of Science ®Google Scholar
• Gylling H, Miettinen TA. The effect of plant stanol- and sterolenriched foods on lipid metabolism, serum lipids and coronary heart disease. Ann Clin Biochem 2005;42:254–63
   PubMed Web of Science ®Google Scholar
• Adult Treatment Panel III. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol. JAMA 2001;285:2486–97
   PubMed Web of Science ®Google Scholar